… ), including dabigatran, rivaroxaban, apixaban, and edoxaban, … of dabigatran against warfarin,
lower doses of dabigatran (… a low dose of dabigatran at 75 mg twice daily for patients with …

… with warfarin and found that rivaroxaban but not apixaban or dabigatran reduced the
thromboembolic risk in frail patients with AF … adherence in patients with non-valvular atrial …

… for atrial fibrillation or patients who have previously taken … , or if their treatment was converted
to warfarin therapy. … in both groups (dabigatran 220 mg, rivaroxaban 20 mg, apixaban 5 mg, …

… for dabigatran 150 mg bid, apixaban 5 mg bid, rivaroxaban 20 … Patients treated with low-dose
DOACs as compared to … aban in Japanese patients with non-valvular atrial fibrillation and …

… databases based on 468 445 patients with nonvalvular AF initiating OAC, dabigatran,
rivaroxaban, and apixaban showed 10% to … Apixaban compared with warfarin in patients with …

… DOACs (rivaroxaban, dabigatran, or apixaban) and 123 patients with … with stable cardiovascular
disease receiving low-dose … non-valvular AF patients in the real-world clinical setting, …

… the Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis (RIWA) studies. The RE-ALIGN
study found that dabigatran was not as effective as warfarin at … Furthermore, apixaban …

… atrial fibrillation (NVAF) is associated with an increased risk of … ) and other clinical tests (such
as blood pressure values) are not … In this study, we used an administrative claims database, …

… Factor Xa inhibitors rivaroxaban, apixaban, and … apixaban was superior to warfarin in
preventing thromboembolic stroke in people with atrial fibrillation, with a lower risk of bleeding …

… to safer and equally effective low-dose drug regimens in the majority of older patients [6]. …
to warfarin was apixaban 5/2.5 mg BID, while dabigatran 150/110 mg BID and rivaroxaban 15/…